Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 3 (2006), Issue 8 (August)

1. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis.
   Hepatology, 44(2): 420-9. [Abstract] [Full-text]
2. HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.
   Hepatology, 44(2): 360-7. [Abstract] [Full-text]
3. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases.
   Hepatology, 44(2): 472-7. [Abstract] [Full-text]
4. Thrombin generation in patients with cirrhosis: the role of platelets.
   Hepatology, 44(2): 440-5. [Abstract] [Full-text]
5. Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma.
   Neurochem Int, 49(4): 372-8. [Abstract] [Full-text]
6. Hepcidin and hemojuvelin gene expression in rat liver damage: in vivo and in vitro studies.
   Am J Physiol Gastrointest Liver Physiol, 291(3): G482-90. [Abstract] [Full-text]
7. Intrarenal octreotide treatment prevents sodium retention in liver cirrhotic rats: evidence for direct effects within the thick ascending limb of Henle's loop.
   Am J Physiol Renal Physiol, 291(3): F537-45. [Abstract] [Full-text]
8. Large scale evaluation of WHO's ultrasonographic staging system of schistosomal periportal fibrosis in Ethiopia.
   Trop Med Int Health, 11(8): 1286-94. [Abstract] [Full-text]
9. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.
   Gut, 55(9): 1296-305. [Abstract] [Full-text]
10. Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial.
    Gut, 55(9): 1290-5. [Abstract] [Full-text]
11. Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats.
    Gut, 55(9): 1306-12. [Abstract] [Full-text]
12. Intrahepatic Glissonian access for segmental liver resection in cirrhotic patients.
    Am J Surg, 192(3): 388-92. [Abstract] [Full-text]
13. Lung cancer surgery in patients with liver cirrhosis.
    Ann Thorac Surg, 82(3): 1027-32. [Abstract] [Full-text]
14. Mineralocorticoid receptor antagonist spironolactone prevents pig serum-induced hepatic fibrosis in rats.
    Transl Res, 148(3): 149-56. [Abstract] [Full-text]
15. Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C.
    Transl Res, 148(3): 128-33. [Abstract] [Full-text]
16. Gene expression profiling in biliary epithelial cells of primary biliary cirrhosis using laser capture microdissection and cDNA microarray.
    Transl Res, 148(3): 103-13. [Abstract] [Full-text]
17. Connective tissue growth factor in serum as a new candidate test for assessment of hepatic fibrosis.
    Clin Chem, 52(9): 1815-7. [Abstract] [Full-text]
18. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma.
    Br J Surg, 93(9): 1091-8. [Abstract] [Full-text]

© 2004-2008 Liver Cirrhosis Research Today. All Rights Reserved.